WaveMan
WaveMan · Company
ADUS · Addus Homecare Corp
> Search tickers & screens ⌘K
LIVE
← All companies

ADUS Addus HomeCare (ADUS) Insider Trading, Ownership & Congress Trades

Healthcare Services · Services-home health care services · CIK 0001468328
Quote by TradingView
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
164
13F, latest reported quarter

What the filings say about ADUS

Insiders, 180 days
-$73.5K net sold
2 sellers · 0% of sales under a 10b5-1 plan

Addus HomeCare insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, Addus HomeCare Corp insiders sold a net $73.5K of stock across 220 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
Dixon Heather Brianne
President and Chief Operating
SELL
2026-06-23 SECtraded 2026-06-22
288
$27.0K
+24.7%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 0.6% of the 44,371 shares held after it.
  • No other insider sold within 30 days.
  • 164 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President and Chief Operating Dixon Heather Brianne sold about $27.0K of ADUS on Jun 22, 2026; 164 funds added in the latest 13F quarter.
Lopez Esteban
Director
SELL
2026-05-22 SECtraded 2026-05-21
250
$23.2K
+30.0%
Context
  • 8 earlier Form 4 trades (code P or S) here by this insider (8 sales), the last on May 19, 2026.
  • The trade is 7.8% of the 3,200 shares held after it.
  • 1 other insider sold within 30 days.
  • 164 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Lopez Esteban sold about $23.2K of ADUS on May 21, 2026; 1 other insider sold within 30 days and 164 funds added in the latest 13F quarter.
Lopez Esteban
Director
SELL
2026-05-21 SECtraded 2026-05-19
250
$23.2K
+30.8%
Context
  • 7 earlier Form 4 trades (code P or S) here by this insider (7 sales), the last on Dec 15, 2025.
  • The trade is 7.2% of the 3,450 shares held after it.
  • 1 other insider sold within 30 days.
  • 164 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Lopez Esteban sold about $23.2K of ADUS on May 19, 2026; 1 other insider sold within 30 days and 164 funds added in the latest 13F quarter.
BLESSING CLIFF DONALD
EVP, Chief Development Officer
SELL
2026-04-22 SECtraded 2026-04-21
178
$16.7K
+28.3%
Context
  • 8 earlier Form 4 trades (code P or S) here by this insider (8 sales), the last on Feb 25, 2026.
  • The trade is 1.5% of the 12,183 shares held after it.
  • 1 other insider sold within 30 days.
  • 164 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, Chief Development Officer BLESSING CLIFF DONALD sold about $16.7K of ADUS on Apr 21, 2026; 1 other insider sold within 30 days and 164 funds added in the latest 13F quarter.
RAINES MONICA
EVP, CCO and Quality Officer
SELL
2026-03-03 SECtraded 2026-03-02
224
$22.9K
+14.7%
Context
  • 15 earlier Form 4 trades (code P or S) here by this insider (15 sales), the last on Feb 25, 2026.
  • The trade is 1.6% of the 13,577 shares held after it.
  • 8 other insiders sold within 30 days.
  • 164 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, CCO and Quality Officer RAINES MONICA sold about $22.9K of ADUS on Mar 2, 2026; 8 other insiders sold within 30 days and 164 funds added in the latest 13F quarter.
220 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 215 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$73.5K over 180 days
more than 71% of Healthcare Services
Congress
no House purchase disclosed in the last 12 months
Funds
164 funds bought in last quarter
more than 67% of Healthcare Services
Revenue
+23.2% year over year
more than 73% of Healthcare Services
Margin
6.7% net margin
more than 76% of Healthcare Services
Buybacks
no share repurchases reported
Short interest
5.2% of the float short (float per yahoo 2026-10-26) · 3.9 days to cover · settled 2026-09-30
more than 65% of Healthcare Services
What changed in the last 30 days
Oct 27Insider selling stopped: no sales in 90 days after 3 in the prior 90
Why it matters
The absence is the signal: 3 sales in one 90-day window and none in the next is a change of behaviour, not a filing.

Watch ADUS

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-0.3%12M
-27%-18%-8%+1%2025-102025-122026-022026-042026-062026-082026-10 2025-11-19 · Anderson Darby sold $2.2M2026-02-24 · ALLISON R DIRK sold $533.6K2026-02-23 · ALLISON R DIRK sold $521.1K2026-02-25 · ALLISON R DIRK sold $249.1K2026-02-24 · POFF BRIAN sold $218.3K2026-02-23 · POFF BRIAN sold $213.5K2026-02-24 · GAFFNEY SEAN sold $87.4K2026-02-25 · POFF BRIAN sold $86.4K2026-02-23 · GAFFNEY SEAN sold $84.7K2026-02-24 · Anderson Darby sold $78.4K2026-02-23 · Anderson Darby sold $76.5K2026-02-23 · TUCKER DAVID W. sold $75.6K2026-02-24 · TUCKER DAVID W. sold $75.6K2026-02-23 · WATTENBARGER MICHAEL D. sold $66.3K2026-02-23 · Stevenson Roberton James sold $64.5K2026-02-24 · WATTENBARGER MICHAEL D. sold $63.6K2026-02-24 · Stevenson Roberton James sold $60.9K2026-02-23 · RAINES MONICA sold $51.2K2026-02-24 · RAINES MONICA sold $46.8K2026-02-25 · GAFFNEY SEAN sold $46.6K2026-02-23 · BLESSING CLIFF DONALD sold $42.6K2026-02-25 · Anderson Darby sold $41.7K2026-02-25 · TUCKER DAVID W. sold $39.9K2026-02-24 · BLESSING CLIFF DONALD sold $37.5K2026-02-25 · WATTENBARGER MICHAEL D. sold $31.6K2026-02-25 · Stevenson Roberton James sold $29.9K2026-06-22 · Dixon Heather Brianne sold $27.0K2026-05-19 · Lopez Esteban sold $23.2K2026-05-21 · Lopez Esteban sold $23.2K2026-02-25 · RAINES MONICA sold $23.1K2026-03-02 · RAINES MONICA sold $22.9K2025-12-05 · Lopez Esteban sold $18.7K2026-02-25 · BLESSING CLIFF DONALD sold $18.6K2026-04-21 · BLESSING CLIFF DONALD sold $16.7K2025-12-15 · Lopez Esteban sold $11.6K2025-12-15 · Lopez Esteban sold $5.7K
Insider sell
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns ADUS: institutional holders (13F)

13F holdings, latest reported quarter
BlackRock, Inc.
3,425,435 sh
$344.2M
Capital Research Global Investors
1,389,907 sh
$139.6M
DIMENSIONAL FUND ADVISORS LP
835,163 sh
$83.9M
VANGUARD CAPITAL MANAGEMENT LLC
789,325 sh
$79.3M
STATE STREET CORP
777,826 sh
$78.1M

Congress trades in ADUS

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

ADUS planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.

ADUS mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Paradigm Value Fund
$1.8M position · as of 2026-06-30
3.2%
DEAN SMALL CAP VALUE
$5.3M position · as of 2026-06-30
2.7%
Wasatch Long/Short Alpha Fund
$1.0M position · as of 2026-06-30
2.7%
Wasatch Small Cap Growth Fund
$29.5M position · as of 2026-06-30
2.5%
Nationwide Renaissance Small Cap Growth Fund
$549.9K position · as of 2026-07-31
2.4%
State Street(R) SPDR(R) S&P(R) Health Care Services ETF
$2.4M position · as of 2026-06-30
1.7%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Executive pay vs shareholder return · Mr. Allison
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$12.2M
$12.0M
$3.3M
-8%
+6%
2024
$5.5M
$7.4M
$2.0M
+7%
+21%
2023
$4.2M
$3.9M
$1.5M
-21%
+29%
2022
$3.7M
$4.2M
$1.5M
-15%
+29%
2021
$3.4M
$1.7M
$1.8M
-20%
+28%
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $73.5K sold by insiders over 180 days, 164 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
NTRACSTLPGNYHIMSWGSPRVATDOCAVAHGHSERABDSXBLLN

ADUS financials

Revenue growth
+23.2%
XBRL, annual
Net margin
6.7%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.5B
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
+7.1%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
$154.8M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
0.05x
long-term 2026-06-30 plus current 2021-06-30 (60 months older than the period end); equity 2026-06-30
Cash flow to debt
2.60x
TTM operating cash flow over long-term 2026-06-30 plus current 2021-06-30 (60 months older than the period end)
Return on equity
+9.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
+7.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
+10.5%
operating income after a 25.2% effective tax rate, over long-term 2026-06-30 plus current 2021-06-30 (60 months older than the period end) plus average of 2025-06-30 and 2026-06-30 minus cash
Return on capital employed
+11.6%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
21.22x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
Enterprise value
$2.2B
market value at close 2026-10-26 on 2026-07-28 shares, plus long-term 2026-06-30 plus current 2021-06-30 (60 months older than the period end), minus cash 2025-03-31
FCF yield
+6.8%
TTM free cash flow over market value at close 2026-10-26
PEG, trailing
0.81x
P/E over trailing EPS growth of 26%: four quarters to 2026-06-30 against the four to 2025-06-30
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$1.4B$1.2B$1.1B$951.1M
Gross profit$461.9M$375.0M$339.9M$299.7M
Operating income$138.6M$102.7M$91.0M$68.7M
Net income$95.9M$73.6M$62.5M$46.0M
EPS (diluted)5.224.233.832.84
Operating cash flow$111.5M$116.4M$112.2M$105.1M
Cashn/a$98.9M$64.8M$80.0M
Long-term debt$121.0M$218.4M$124.1M$131.8M
SEC XBRL, fiscal years, as known on 2026-10-27

ADUS Stock Sonar score 6/7 axes

Find similar shapesCompare

ADUS ranks highest on financial health (84th percentile) and growth (73rd), and lowest on risk and compliance (34th), among Healthcare Services peers.

ProfitHealthGrowthInsidersInstitutionsRisk
Profitability
67
Inputs
  • Return on equity+9.7% · 65 pct, sector of 70
  • Return on assets+7.4% · 82 pct, sector of 88
  • Return on invested capital+10.5% · 44 pct, universe of 1,069
  • Return on capital employed+11.6% · 76 pct, sector of 68
Financial health
84
Inputs
  • Debt to equity0.05x · 78 pct, sector of 61
  • Cash flow to debt2.60x · 89 pct, sector of 66
Growth
73
Inputs
  • Revenue growth, YoY+23.2% · 73 pct, sector of 87
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
35
Inputs
  • Net Form 4 buying (codes P and S), 180d-$74K · 70 pct, sector of 64
  • Insider buyers, 180d0 · 0 pct, sector of 64
Institutional and government
52
Inputs
  • Funds adding, latest quarter164 · 67 pct, sector of 73
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quarters$240K · 38 pct, universe of 1,063
Risk and compliance
34
Inputs
  • Short interest, % of float+5.2% · 50 pct, sector of 95
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+17.3% · 18 pct, sector of 72
1 not measured: US patents
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

ADUS filings, in plain words

Are Addus HomeCare insiders buying or selling ADUS?

In the 180 days to 2026-10-27, Addus HomeCare insiders were net sellers, a net $73.5K across purchases and sales reported on Form 4, by 2 sellers.

Read the full summary

In the 180 days to 2026-10-27, Addus HomeCare insiders were net sellers of ADUS, a net $73.5K across purchases and sales reported on Form 4 by 2 sellers. None of the 3 insider sales was flagged as made under a Rule 10b5-1 plan. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies